Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 908 to 957 of 3730 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
454\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 1 (esg1). [source:swissprot;acc:q04724]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3219.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3174.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01402\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
455\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ga binding protein alpha chain (gabp-alpha subunit) (transcription factor e4tf1-60) (nuclear respiratory factor-2 subunit alpha). [source:swissprot;acc:q06546]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4890.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14731\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2403.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2371.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01362\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
456\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cop9 signalosome complex subunit 1 (g protein pathway suppressor 1) (gps1 protein) (mfh protein). [source:swissprot;acc:q13098]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
17356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17126\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01343\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ga binding protein beta-2 chain (gabp-beta-2 subunit) (transcription factor e4tf1-47) (gapbp-2) (nuclear respiratory factor-2 subunit gamma). [source:swissprot;acc:q06545]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4890.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14731\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
457\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna mismatch repair protein mlh1 (mutl protein homolog 1). [source:swissprot;acc:p40692]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1562.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1541.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01341\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 23 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-23kd) (ci-23kd) (tyky subunit). [source:swissprot;acc:o00217]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4890.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.95\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14731\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
458\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation of very long chain fatty acids protein 1 (cgi-88). [source:swissprot;acc:q9bw60]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4890.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.96\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 5 (tap-like protein 1) (tapl-1). [source:swissprot;acc:q9h1b4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2633.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2668.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01327\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
459\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
intersectin 1 (sh3 domain-containing protein 1a) (sh3p17). [source:swissprot;acc:q15811]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3774.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3821.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01266\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myc proto-oncogene protein (c-myc). [source:swissprot;acc:p01106]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4892.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5611.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14704\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
460\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
intersectin 2 (sh3 domain-containing protein 1b) (sh3p18) (sh3p18-like wasp associated protein). [source:swissprot;acc:q9nzm3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3693.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3739.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01259\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nnp-1 protein (novel nuclear protein 1) (nucleolar protein nop52) (nop52) (d21s2056e). [source:swissprot;acc:p56182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3790.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4346.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14693\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
461\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase i 16 kda polypeptide (ec 2.7.7.6) (rpa16). [source:swissprot;acc:q9y2s0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1915.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1892.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01229\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
grb2-related adaptor protein. [source:swissprot;acc:q13588]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5986.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6865.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14683\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
462\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine rich repeat (in flii) interacting protein 1. [source:refseq;acc:nm\_004735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11170.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11305\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01202\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ret finger protein 2 (leukemia associated protein 5) (b-cell chronic lymphocytic leukemia tumor suppressor leu5) (putative tumor suppressor rfp2) (tripartite motif protein 13). [source:swissprot;acc:o60858]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
11383.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9926.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14674\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
463\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3720.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4264.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1463\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrofolate reductase (ec 1.5.1.3). [source:swissprot;acc:p00374]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1262.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1248.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01163\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
464\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone acetyltransferase type b subunit 2 (retinoblastoma binding protein p46) (retinoblastoma-binding protein 7) (rbbp-7). [source:swissprot;acc:q16576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4858.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5568.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1461\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
maleylacetoacetate isomerase (ec 5.2.1.2) (maai) (glutathione s- transferase zeta 1) (ec 2.5.1.18) (gstz1-1). [source:swissprot;acc:o43708]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2290.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2264.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01136\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
465\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homer, neuronal immediate early gene, 1b. [source:refseq;acc:nm\_004272]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6323\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6254.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01102\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor e2f1 (e2f-1) (retinoblastoma binding protein 3) (rbbp-3) (prb-binding protein e2f-1) (pbr3) (retinoblastoma-associated protein 1) (rbap-1). [source:swissprot;acc:q01094]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3847.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4409.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14605\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
466\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ischemia/reperfusion inducible protein. [source:refseq;acc:nm\_024640]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1467.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1483.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01082\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor e2f2 (e2f-2). [source:swissprot;acc:q14209]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3847.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4409.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14605\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
467\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
metastasis-associated protein mta1. [source:swissprot;acc:q13330]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4864.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5573.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14583\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to cg7020 gene product (fragment). [source:sptrembl;acc:q96ib4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2806.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2782.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00856\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
468\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin assembly factor 1 subunit c (caf-1 subunit c) (chromatin assembly factor i p48 subunit) (caf-i 48 kda subunit) (caf-ip48) (retinoblastoma binding protein p48) (retinoblastoma-binding protein 4) (rbbp-4) (msi1 protein homolog). [source:swissprot;acc:q09028]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4869.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5578.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14558\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 20/15 kda subunits (tafii- 20/tafii-15) (tafii20/tafii15). [source:swissprot;acc:q16514]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
599.896\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
604.911\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00836\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
469\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proliferating-cell nucleolar antigen p120 (proliferation-associated nucleolar protein p120). [source:swissprot;acc:p46087]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3831.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4388.74\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14554\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor btf3 homolog 3. [source:swissprot;acc:q13892]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.759\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.565\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00822\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
470\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
block of proliferation 1. [source:swissprot;acc:q14137]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3796.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4348.59\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1455\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin interacting protein e; huntingtin interactor protein e. [source:refseq;acc:nm\_007076]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
39165\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
39485\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00817\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
471\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase 12 (ec 2.7.1.37) (extracellular signal-regulated kinase 6) (erk-6) (erk5) (stress-activated protein kinase-3) (mitogen-activated protein kinase p38 gamma) (map kinase p38 gamma). [source:swissprot;acc:p53778]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal recognition particle receptor alpha subunit (sr-alpha) (docking protein alpha) (dp-alpha). [source:swissprot;acc:p08240]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3855.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3825.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00785\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
472\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h3.3 (h3.a) (h3.b) (h3.3q). [source:swissprot;acc:p06351]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3889.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3919.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00765\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sphingosine kinase 1 (ec 2.7.1.-) (sk 1) (spk 1). [source:swissprot;acc:q9nya1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
473\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj1099d15.1 (putative dnaj protein). [source:sptrembl;acc:q9h4j9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3889.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3919.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00765\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-n-acetylglucosamine--dolichyl-phosphate n- acetylglucosaminephosphotransferase (ec 2.7.8.15) (gpt) (g1pt) (n-acetylglucosamine-1-phosphate transferase) (glcnac-1-p transferase). [source:swissprot;acc:q9h3h5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
474\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 12 (26s proteasome regulatory subunit p55). [source:swissprot;acc:o00232]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2281.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2263.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00763\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho-gtpase-activating protein 7 (rho-type gtpase-activating protein 7) (deleted in liver cancer 1 protein) (dlc-1) (hp protein) (star-related lipid transfer protein 12) (stard12) (start domain-containing protein 12). [source:swissprot;acc:q96qb1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
475\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-1-acid glycoprotein 2 precursor (agp 2) (orosomucoid 2) (omd 2). [source:swissprot;acc:p19652]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2319.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2335.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00722\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
map kinase-activated protein kinase 2 (ec 2.7.1.-) (mapk-activated protein kinase 2) (mapkap kinase 2) (mapkapk-2). [source:swissprot;acc:p49137]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
476\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead/h (asp-glu-ala-asp/his) box polypeptide 11; dead/h box-11 (chl1-related helicase gene-1); yeast chl1 homolog. [source:refseq;acc:nm\_030655]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1362.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1372.31\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00716\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-6 chain precursor. [source:swissprot;acc:q15825]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
477\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
426\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
429\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00704\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nitrogen fixation cluster-like. [source:refseq;acc:nm\_014301]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
478\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 13 (stard13) (start domain- containing protein 13) (46h23.2). [source:swissprot;acc:q9y3m8]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
survival motor neuron protein (component of gems 1) (gemin1). [source:swissprot;acc:q16637]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
705.758\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
701.071\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00669\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
479\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1318.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1310.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00587\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/